MedTrace Logo

To Evaluate the Safety/Tolerability and Pharmacokinetic Characteristics in Healthy Volunteers

NCT06703710 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2025-01-13

No results posted yet for this study

Summary

This clinical trial is a randomized, double-blind, placebo-controlled, single ascending dose, phase 1 clinical trial to evaluate the safety/tolerability and pharmacokinetic characteristics, and to explore food effect and ethnic difference of JW2286 after oral administration in healthy adults.

Conditions

  • Healthy

Interventions

DRUG

JW2286

a single administration of JW2286 per dose

DRUG

Placebo of JW2286

a single administration of Placebo of JW2286 per dose

Sponsors & Collaborators

Principal Investigators

  • SeungHwan Lee · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
SEQUENTIAL

Eligibility

Min Age
19 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-06
Primary Completion
2025-11-30
Completion
2026-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06703710 on ClinicalTrials.gov